NewAtom Labs

NewAtom Labs, a cutting-edge, digital-first CDMO specializing in small molecule drug substances. Our expertise spans flow chemistry, biocatalysis, ADC, and chiral chemistry. We excel in rapid scale-ups and customized R&D solutions, ensuring your projects transition smoothly from concept to reality. Our pilot and manufacturing facilities, audited by both the US FDA and EU GMP, support the manufacturing of Intermediates/APIs from preclinical to commercial launch. By leveraging digital technologies like AI and VR/AR, we enhance R&D and manufacturing outcomes, delivering superior results.